Sector: Consumer Non-Cyclicals | Industry: Personal Products |
See Regulatory Filings on SEC |
Company Contact | |
Address: | ATTN: D. MATTHEW DORNY 75 WEST CENTER ST PROVO UT 84601 |
Tel: | N/A |
Website: | https://www.nuskin.com |
IR: | See website |
Key People | ||
Steven J. Lund Executive Chairman of the Board | Ryan S. Napierski President, Chief Executive Officer, Director | James D. Thomas Chief Financial Officer, Executive Vice President |
Joseph Y. Chang Executive Vice President - Product Development, Chief Scientific Officer | Chayce D. Clark Executive Vice President, General Counsel | Steven Keith Hatchett Executive Vice President, Chief Product Officer |
Business Overview |
Nu Skin Enterprises, Inc. is an integrated beauty and wellness company. The Company develops and distributes a comprehensive line of beauty and wellness solutions in approximately 50 markets worldwide. The Company has three brands, Nu Skin, a beauty brand; Pharmanex, a wellness brand; and ageLOC, an anti-aging brand. It develops and distributes products in two categories, beauty products and wellness products. The Company operates through seven segments: Mainland China; South Korea; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Australia, New Zealand and other markets; Americas, which includes Canada, Latin America and the United States; Japan; Hong Kong/Taiwan, which also includes Macau; and Europe, Middle East and Africa, which includes markets in Europe, as well as Israel and South Africa. The Company's Rhyz strategic investment arm also includes two additional segments: Manufacturing and Rhyz other. |
Financial Overview |
For the fiscal year ended 31 December 2023, Nu Skin Enterprises, Inc. revenues decreased 12% to $1.97B. Net income decreased 92% to $8.6M. Revenues reflect Nu Skin segment decrease of 15% to $1.75B. Net income also reflects Stock-based Compensation in SGA increase of 26% to $15.6M (expense). Dividend per share increased from $1.54 to $1.56. Basic Earnings per Share excluding Extraordinary Items decreased from $2.10 to $0.17. |
Employees: | 3,700 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $918.71M as of Dec 31, 2023 |
Annual revenue (TTM): | $1,969M as of Dec 31, 2023 |
EBITDA (TTM): | $138.98M as of Dec 31, 2023 |
Net annual income (TTM): | $8.60M as of Dec 31, 2023 |
Free cash flow (TTM): | -$17.47M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $235.22M as of Dec 31, 2023 |
Shares outstanding: | 49,420,882 as of Jan 31, 2024 |
Index Membership: | S&P 600 Small Cap |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |